Sign up here and take full advantage of MicrobiomePost‘s features.
Sign up

Developing psychobiotic LBPs tackling the gut-brain axis

Anna Chwalibóg, Chief Product Officer at Integral Solutions, talks about the opportunity to develop next-generation microbiome-based therapeutics for mental health and cognitive enhancement.

During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost discussed with Anna Chwalibóg, Chief Product Officer at Integral Solutions, about the opportunity to develop next-generation microbiome-based therapeutics for mental health and cognitive enhancement using, in particular, CRISPR genome engineering.

Most recent

HCPs Area

Industry

MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome

Published by Clorofilla Srl

Facebook-f Linkedin Twitter Youtube
© 2016-2024 Clorofilla Scientific Publishing

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

© ALL RIGHTS RESERVED

Read MicrobiomePost’s Privacy Policy